Advertisement

Philippines launches probe into dengue vaccine scare

From BBC - December 3, 2017

The Philippines has launched an investigation into the immunisation of 730,000 children with a dengue vaccine that could pose health risks.

Last week French drug company Sanofi announced their vaccine could worsen the potentially deadly disease in people not previously infected.

The public immunisation programme was suspended on Friday.

Dengue fever affects more than 400 million people a year around the world.

The mosquito-borne disease is a leading cause of serious illness and death among children in some Asian and Latin American countries, according to the World Health Organisation.

Sanofi's Dengvaxia is the first-ever approved Dengue vaccine. In addition to the Philippines, Dengvaxia has also been approved in Mexico, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, Indonesia, Thailand and Singapore, Sanofi said last year.

Sanofi said in a press conference on Monday that there had been no reported deaths related to its dengue vaccine in the Philippines.

Advertisement

Continue reading at BBC »